Dr. David J. Sugarbaker

EGFR TKIs: A Marathon or Sprint?

Jessica S. Donington, MD, MSCR

CAR-T Cells for Lung Cancer: Q&A with Dr. Charu Aggarwal

The IASLC Fight Against Lung Cancer in Peru and Latin America

KEYNOTE-042: No Hard and Fast Rules for First-Line Pembrolizumab Regarding PD-L1–Positive Disease

Circulating Tumor Cell–Derived Patient eXplants: A New Tool for SCLC Research

NCI Selects Five Teams of Researchers to Expand Discovery of Predictive Biomarkers for Immunotherapy

The Budget Landscape with Dr. Douglas R. Lowy

The IASLC Issues Liquid Biopsy Statement to Aid Understanding of Rapid Innovation

Global Insights on New Clinical Practice Guideline for the Treatment of Malignant Pleural Mesothelioma

Updated Results from the Phase III ALEX Trial: Embracing Hazard Ratios